Neurol. praxi. 2015;16(1):24-29

Treatment of spasticity

MUDr. František Cibulčík, PhD.
Neurologická klinika LF SZU a UN Bratislava Ružinov

Spasticity is a serious manifestation of central nervous system disease causing significant deterioration in the quality of life of the patient. It is encountered in aetiologically diverse types of brain and/or spinal cord injury – most commonly stroke, poliomyelitis, multiple sclerosis, and nervous system trauma. Treatment of spasticity is characteristic for its comprehensive nature taking into account the specific aetiology as well as the extent and duration of nervous system injury. It consists of a combination of three groups of therapeutic strategies: rehabilitation, pharmacological, and surgical treatment. The paper presents an overview of the guidelines on treatment of spasticity with a special regard to the use of treatment with botulinum toxin A in the cases of spasticity in poliomyelitis and post-stroke spasticity.

Keywords: spasticity, botulinum toxin A, poliomyelitis, stroke

Published: January 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cibulčík F. Treatment of spasticity. Neurol. praxi. 2015;16(1):24-29.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bohannon RW, Smith MB. Interrater reliability of modified Asworth scale of muscle spasticity. Phys Ther. 1986; 67: 206-207. Go to original source...
    2. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J. 1989; 65: 208-210. Go to original source... Go to PubMed...
    3. Delgado MR, Hirtz D, Aisen M. Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology 2010; 74: 336-343. Go to original source... Go to PubMed...
    4. Ehler E. Současná terapie spasticity se zaměřením na lokální aplikaci botulotoxínu. Neurol. praxi 2001; 3: 128-132.
    5. Ehler E, Vaňásková E, Štětkářová I. Standard komplexní léčby spasticity po cévní mozkové příhodě. Cesk Slov Neurol N 2009; 72: 179-181.
    6. Kaňovský P, Bareš M, Streitová H. Abnormalities of cortical excitability and cortical inhibition in cervical dystonia: evidence from somatosensory evoked potentials and paired transcranial magnetic stimulation recordings. J Neurol 2003; 250: 42-51. Go to original source... Go to PubMed...
    7. Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum - A toxin: preliminary investigation. J Pediatr Orthop 1993; 13: 489-445. Go to original source... Go to PubMed...
    8. National Collaborating Centre for Women's and Children's Health. Spasticity in children and young people with non-progressive brain disorders. Management of spasticity and co-existing motor disorders and their early musculosceletal complications. London (UK): National Institute for Health and Clinical Excellence (NICE) 2012.
    9. Simpson DM, Gracies JM, Graham HK. Assesment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 2008; 70: 1691-1698. Go to original source... Go to PubMed...
    10. Stempten L, Tsai T. Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 2000; 79: 536-541. Go to original source...
    11. Spasticity in adults: management using botulinum toxin. National Guidelines. Royal College of Physicians, London 2009.
    12. Štetkářová I. Léčba spasticity u dospělých. Med praxi 2012; 9: 124-126.
    13. Ward A. Long-term modification of spasticity. J Rehabil Med 2003; 35: 60-65. Go to original source... Go to PubMed...
    14. Watkins CL, Leathley MJ, Gregson JM. Prevalence of spasticity post-stroke. Clin Rehabil 2002; 16: 515-522. Go to original source... Go to PubMed...
    15. Wissel J, Ward AB, Ertgaard P. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41: 13-25. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.